DDQ – reagent of the month – October
Reagent of the month – DDQ and quinone-derived oxidants
Reagents derived from p-quinone such as 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) or p-chloranil are used in a wide range of applications in organic synthesis as quantitative oxidants, however, numerous quinone catalysed transformations using other chemicals or electrodes as quantitative oxidants have recently been developed (https://doi.org/10.1002/anie.201505017)
Synthesis
DDQ can be made by chlorinating 2,3-dicyanohydroquinone and then oxidising it with lead (IV) oxide.
Applications of DDQ in the synthesis
DDQ is probably best known for its ability to dehydrogenate hydroaromatic compounds to their aromatic analogues, which is used as the final step in many heterocyclic aromatic compound syntheses (e. g. Hantzsch synthesis of pyridine derivatives), but it can also be used for selective oxidation of alcohols and ethers in benzylic or allylic positions to corresponding aldehydes or ketones (https://doi.org/10.1002/).
This oxidation is destructive in the case of ethers and works better on more activated benzyl derivatives. In wet DCM can thus be used to selectively deprotect Nap (2-naphytlymethyl) or PMB (p-methoxybenzyl) groups while leaving benzyl groups untouched, which is commonly used in carbohydrate chemistry (https://doi.org/10.1016/S0040-4020(01)90593-9; https://doi.org/10.1016/S0040-4039(01)00563-9).
DDQ is used in a variety of oxidative C-C Scholl type coupling reactions on both aromatic and aliphatic substrates. Cyclotrimerization of substituted benzenes (https://doi.org/10.1016/j.tetlet.2014.12.141) and many intramolecular cyclizations (https://doi.org/10.1021/jo401807x) are examples of such coupling.
Industrial applications of DDQ
DDQ is used in numerous syntheses of pharmaceuticals for dehydrogenation of hydroaromatic intermediates. The dehydrogenation step in the synthesis of the anti-obesity and cardiovascular disease prevention drug Rosuvastatin is one example of such use. S-methylisothiourea is first condensed with ethyl 2-(4-fluorobenzylidene)-4-methyl-3-oxopentanoate, and the resulting 1,2-dihydropyrimidine derivative is aromatized by dehydrogenation with DDQ. (https://doi.org/10.1016/S0968-0896(96)00248-9)
We have a lot of experience at Santiago lab with various oxidation reagents (such as DDQ) for performing difficult syntheses. If you want to learn more about our services, discuss specific research or custom synthesis project, or receive a proposal, please contact Krystof Sigut at krystof.sigut@santiago-lab.com
or reach him on the phone +420 776 750 591.
[vc_row][vc_column][insignia_section_heading title="Drop us a line" subtitle="We will respond as soon as
possible, typically within 48 hours." align="text-center" c_margin_top="20" c_margin_bottom="20"
add_icon="" font_weight="default" sub_font_weight="default"][contact-form-7 id="13965"][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height="80px"][vc_column width="1/1"]
OUR CASE STUDY
Scale-up to accelerate drug discovery
Our experience helped overcome development hurdles for potential cancer & mental health drugs.
Read moreEmpowering neuro research with pro-N6pA
Sigut Labs scaled up pro-N6pA production, simplifying AMPylation research & boosting accessibility.
Read moreADC development leaps with new linkers
Novel linker design expedited ADC advancement, leading to promising lead compounds faster.
Read moreLincomycin derivative scale-up
Over 30 g of the desired product with exceptional purity was obtained through our optimized procedure.
Read morePurifying 350 kg of vitamin K2 oil
Our innovative scale-up technology helped to reduce the client’s purification process from days to hours.
Read moreCustom synthesis
Providing for a custom synthesis of previously reported molecules using described synthetic procedures.
Contract research
Developing novel synthetic routes to provide undescribed compounds in organic, bioorganic, and medicinal chemistry.
Scale-Up
Helping you go from lab scales to an industrial scale by applying our cutting-edge instrumentation.